Pascal Mayer is a scientific innovator and inventor of various technologies with large market value.
His inventions lead to the filing of 12 patent families including the core patents behind the world's leading sequencing technology (Illumina), and biofilm measurement technologies (Biofilm Control).
Prior to Alphanosos, key experience included VP drug-discovery at BioFilm Control, CEO at Haploys, CSO at Manteia Predictive Medicine (a spin-off from Serono), and Scientist at Glaxo-Wellcome and later Serono.
Daniel Valtueña Maestre
Daniel Valtueña Maestre is a pharmaceutical entrepreneur with legal and financial background.
Prior to Alphanosos key experience included CEO at Filaxis (Speciality Pharma developed internationally and sold to Fresenius), CFO at Manteia Predictive Medicine (a spin-off from Serono), VP Taxes(Finances) at Serono, and Senior Legal Consulting Manager at Price Waterhouse.